ArticleFEMS microbiology letters2026
Rising Vibrio vulnificus infections in Northern Europe linked to environmental reservoirs sustaining clinical pathogenicity.
Article in FEMS microbiology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Vibrio vulnificus is one of the most lethal marine pathogens, causing wound infections, septicemia, and necrotizing soft tissue infection with case fatality rates exceeding 20%-50%. In Northern Europe, incidence is rising alongside warming coastal waters. The genomic relatedness between environmental and clinical isolates and the long-term persistence of virulent clades in temperate waters remains poorly defined. An analysis of 117 V. vulnificus genomes, including 60 newly sequenced (36 environmental isolates and 24 clinical isolates from Denmark, 1994-2023), 27 publicly available Nordic clinical genomes, and 30 comparative reference public genomes were analysed. Comparative genomics, virulence gene profiling, pangenome analysis, and core-genome SNP (Single Nucleotide Polymorphism) phylogeny were used to define clade structure, persistence, and genetic determinants of pathogenicity. Four major clades were identified; three (C2-C4) persisted for up to three decades and contained both clinical and environmental isolates. Clonal pairs (≤40 SNPs) linked environmental and clinical sources across up to 8 years and multiple countries. The virulence gene repertoire including the major virulence factors MARTX toxin genes (rtxA/B/C/D), chiRP (chitin-regulated pilus), flp2/tad2 pili (fimbrial low-molecular-weight protein/tight adherence pili), ilpA (immunogenic lipoprotein A), and ompU (outer membrane porin), and vvhA (V. vulnificus hemolysin).) were present in both environmental and clinical isolates. All isolates carried the tetracycline resistance gene tet(34). We report that environmental aquatic reservoirs harbor fully virulent V. vulnificus lineages, making human infections exposure-driven rather than the result of emerging novel lineages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.